Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations

Kensuke Nakagawara; Koichi Fukunaga; Masanori Kaji; Hirofumi Kamata; Takashi Inoue; Hidefumi Koh; Keeya Sunata; Naoki Hasegawa; Toshio Odani; Takanori Kanai∥; Makoto Ishii; Keigo Kobayashi; Keiko Ohgino; Soichiro Ueda; Emiko Matsuyama; Jun Miyata; Mayuko Watase; Rie Baba; Hideki Terai; Atsuho Morita; Kota Ishioka; Saeko Takahashi; Ayaka Saito; Takanori Asakura; Ichiro Nakachi; Junko Kagyo; Ho Namkoong; Kazuma Yagi; Morio Nakamura; Hatsuyo Takaoka; Hiromu Tanaka; Yohei Funatsu; Shotaro Chubachi; Ichiro Kawada; Kengo Otsuka; Yuko Kitagawa; Toshiyuki Hirano; Masahiko Okada; Tetsuya Shiomi; Daisuke Arai; Naoki Miyao; Fumimaro Ito

doi:10.1016/j.jvacx.2023.100381

Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations

Kensuke Nakagawara(Keio University), Koichi Fukunaga(Keio University), Masanori Kaji(Keio University), Hirofumi Kamata(Keio University), Takashi Inoue(Ome Municipal General Hospital), Hidefumi Koh(Tachikawa Hospital), Keeya Sunata(Keio University), Naoki Hasegawa(Keio University), Toshio Odani(National Hospital Organization Hokkaido Medical Center), Takanori Kanai∥(Keio University), Makoto Ishii(Tokyo Medical and Dental University), Keigo Kobayashi(Osaka Gakuin University), Keiko Ohgino(Keio University), Soichiro Ueda(Social Insurance Saitama Chuo Hospital), Emiko Matsuyama(Keio University), Jun Miyata(Kyoto University), Mayuko Watase(Keio University), Rie Baba(Saiseikai Utsunomiya hospital), Hideki Terai(Kitasato Institute Hospital), Atsuho Morita(Keio University), Kota Ishioka(Keio University), Saeko Takahashi(Saiseikai Central Hospital), Ayaka Saito(Keio University), Takanori Asakura(Keio University), Ichiro Nakachi(Saiseikai Utsunomiya hospital), Junko Kagyo(Kawasaki Municipal Hospital), Ho Namkoong(Keio University), Kazuma Yagi(Keio University), Morio Nakamura(Saiseikai Central Hospital), Hatsuyo Takaoka(Keio University), Hiromu Tanaka(Keio University), Yohei Funatsu(Keio University), Shotaro Chubachi(Keio University), Ichiro Kawada(Keio University), Kengo Otsuka(Keio University), Yuko Kitagawa(Keio University), Toshiyuki Hirano(Sapporo Kosei General Hospital), Masahiko Okada(Keio University), Tetsuya Shiomi(keiyu Hospital), Daisuke Arai(Chiba University), Naoki Miyao, Fumimaro Ito(Keio University)

Vaccine X

September 1, 2023

10.1016/j.jvacx.2023.100381

Cited by 5

Related Papers

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

|Nature|2009|1.1k

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

|The Lancet Oncology|2019|642

Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer

|Science Translational Medicine|2013|565

Epigenetic regulation of the alternatively activated macrophage phenotype

|Blood|2009|491

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized Study

|American Journal of Respiratory and Critical Care Medicine|2018|343